Two Sigma Advisers Reduces $10M in Asana, Inc. ($ASAN)
Key Points
- Two Sigma Advisers changed its Asana, Inc. ($ASAN) stake by 100.0% last quarter, cutting to 0 shares.
- Wall Street's consensus rating on $ASAN is Hold and an average price target of $9.13.
- $ASAN last traded around $7.39.
Two Sigma Advisers reduced its position in Asana, Inc. ($ASAN), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Asana, Inc. after selling 1,397,100 shares during the quarter.
Asana, Inc. ($ASAN) Stock
Asana, Inc. Earnings
Analysts Set New Price Targets
About Asana, Inc.
Asana, Inc., together with its subsidiaries, operates a work management software platform for individuals, team leads, and executives in the United States and internationally. The company provides work management products; Asana Work Graph, a proprietary data model that maps; AI Teammates, collaborative AI agents that work like real teammates to accelerate outcomes; Asana AI Studio, is a complementary product for designing AI workflows to automate routine, structured, and repeatable processes; and Asana Gov, a secure platform designed for government agencies and regulated industries to deliver mission-critical programs. The company also offers a platform that supports project and process management, goals and business reporting, resource management, and strategic planning and portfolio management. The company uses a hybrid go-to-market approach, combining a product-led model, direct sales, and channel partners to serve customers in various industries, such as technology, retail, education, non-profit, government, healthcare, hospitality, media, manufacturing, professional services, and financial services. The company was formerly known as Smiley Abstractions, Inc. and changed its name to Asana, Inc. in July 2009. Asana, Inc. was incorporated in 2008 and is headquartered in San Francisco, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.